Composition of tegafur, Indole-3-carbinol and either catechin, kaempherol, myricetin or luteolin for potentiating antitumour effect and for treating tumours
Novel pharmaceutical compostion for treating cancer, preferably malignant cancer by way of enteral use have been described, which contain Indole-3-carbinol and one of natural flavonoid derivative, preferably Catechin, Kaempferol, Myricetin, Luteolin and a cancer chemotherapeutic agent TEGAFUR.